Coronaviurs Vaccine

A global push is on to develop a vaccine to slow the spread of Covid-19, and experts hope several will be ready in 2021. Yet even with one, the coronavirus is likely to remain with us for years, demanding long efforts to find a cure for those who still fall sick.

A 30-year-old man was on Friday given the first dose of undertrial coronavirus vaccine named as COVAXIN in Delhi's All India Institute Of Medical Sciences.

India's COVID-19 vaccine candidates will go through a rigorous evaluation process that will not be compromised, the government's Principal Scientific Advisor K Vijay Raghavan said on Friday, indicating that the ICMR-Bharat Biotech vaccine is unlikely to be out by August 15.

A global push is on to develop a vaccine to slow the spread of Covid-19, and experts hope several will be ready in 2021. Yet even with one, the coronavirus is likely to remain with us for years, demanding long efforts to find a cure for those who still fall sick.

A 30-year-old man was on Friday given the first dose of undertrial coronavirus vaccine named as COVAXIN in Delhi's All India Institute Of Medical Sciences.

India's COVID-19 vaccine candidates will go through a rigorous evaluation process that will not be compromised, the government's Principal Scientific Advisor K Vijay Raghavan said on Friday, indicating that the ICMR-Bharat Biotech vaccine is unlikely to be out by August 15.